増殖糖尿病網膜症 PDR
WordNet
- suffering from diabetes
- someone who has diabetes
- of or relating to or causing diabetes
- a disease of the retina that can result in loss of vision
PrepTutorEJDIC
- 糖尿病の / 糖尿病患者
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Domain I-IV of β2-glycoprotein I inhibits advanced glycation end product-induced angiogenesis by down-regulating vascular endothelial growth factor 2 signaling.
- Wang QQ1, Zhou SJ1, Meng ZX1, Wang J1, Chen R1, Lv L1, Li CJ1, Yu DM1, Yu P1.
- Molecular medicine reports.Mol Med Rep.2015 Mar;11(3):2167-72. doi: 10.3892/mmr.2014.2970. Epub 2014 Nov 18.
- Advanced glycation end products (AGEs) are a contributing factor in the angiogenesis that is characteristic of proliferative diabetic retinopathy. However, a previous study made a promising observation that domain I‑IV of β2‑glycoprotein I (DI‑IV) inhibits angiogenesis in human umbilical vei
- PMID 25405610
- Reevaluating the definition of intraretinal microvascular abnormalities and neovascularization elsewhere in diabetic retinopathy using optical coherence tomography and fluorescein angiography.
- Lee CS1, Lee AY2, Sim DA3, Keane PA4, Mehta H1, Zarranz-Ventura J5, Fruttiger M6, Egan CA7, Tufail A8.
- American journal of ophthalmology.Am J Ophthalmol.2015 Jan;159(1):101-110.e1. doi: 10.1016/j.ajo.2014.09.041. Epub 2014 Oct 25.
- PURPOSE: To evaluate the agreement between clinical examination, spectral-domain ocular coherence tomography (SD OCT), and fluorescein angiography (FA) in diagnosing intraretinal microvascular abnormality (IRMA) and neovascularization elsewhere (NVE) and define the SD OCT features that differentiate
- PMID 25284762
- The carboxyl terminus of VEGF-A is a potential target for anti-angiogenic therapy.
- Carter JG1, Gammons MV, Damodaran G, Churchill AJ, Harper SJ, Bates DO.
- Angiogenesis.Angiogenesis.2015 Jan;18(1):23-30. doi: 10.1007/s10456-014-9444-3. Epub 2014 Oct 2.
- Anti-VEGF-A therapy has become a mainstay of treatment for ocular neovascularisation and in cancer; however, their effectiveness is not universal, in some cases only benefiting a minority of patients. Anti-VEGF-A therapies bind and block both pro-angiogenic VEGF-Axxx and the partial agonist VEGF-Axx
- PMID 25274272
Japanese Journal
- 糖尿病網膜症(増殖網膜症)の手術 (AYUMI 糖尿病性網膜症Update)
- CLINICAL INVESTIGATION : Comparison of microinsicion vitrectomy and conventional 20-gauge vitrectomy for severe proliferative diabetic retinopathy
- Japanese journal of ophthalmology : the official international journal of the Japanese Ophthalmological Society 59(5), 288-294, 2015-09
- NAID 40020590680
- 臨床報告 増殖糖尿病網膜症に対する硝子体手術10年後視力予後因子の統計学的検討
Related Links
- ... abnormal blood vessels can develop and leak blood into the center of the eye, blurring vision. This is proliferative retinopathy and is the fourth and most advanced stage of the disease. Fluid can leak into the center of the It can ...
- Diabetic Retinopathy is a disease that does not discriminate based on race, age, or gender. But diabetic retinopathy can be prevented by controlling your diabetes, watching your diet, and taking care of your overall health. ... Diabetic ...
★リンクテーブル★
[★]
増殖糖尿病網膜症 proliferative diabetic retinopathy
[★]
前増殖糖尿病網膜症, PPDR
[★]
- 関
- diabetes、diabetes mellitus、diabetic patient、diabetic subject、DM
[★]
- 関
- multiplicative、productive、productively、proliferating
[★]
糖尿病性網膜症, DR